Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kaushansky K . On the molecular origins of the chronic myeloproliferative disorders: it all makes sense. Blood 2005; 105: 4187–4190.

    Article  CAS  Google Scholar 

  2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.

    Article  CAS  Google Scholar 

  3. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148.

    Article  CAS  Google Scholar 

  4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387–397.

    Article  CAS  Google Scholar 

  5. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790.

    Article  CAS  Google Scholar 

  6. Kralovics R, Guan Y, Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Exp Hematol 2002; 30: 229–236.

    Article  CAS  Google Scholar 

  7. Imbert M, Pierre R, Thiele J, Vardiman JW, Brunning RD, Flandrin G . Essential thrombocythaemia. In: Jaffe ES, Harris NL, Stein H et al (eds). WHO Classification of Tumors: Tumors of Hematopoietic and Lymphois Tissues. Lyon: IARC Press, 2001, pp 39–41.

    Google Scholar 

  8. Vannucchi AM, Grossi A, Pancrazzi A, Antonioli E, Guglielmelli P, Balestri F et al. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia. Br J Haematol 2004; 127: 214–219.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Italian Ministry of Health (Progetti di Ricerca di Interesse Nazionale 2003, #06488803); funds from the University of Florence (ex-60%), Associazione Italiana per la Ricerca sul Cancro, Milano, and Ente Cassa di Risparmio di Firenze. AP was the recipient of a fellowship from Associazione Italiana per le Leucemie, Firenze.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A M Vannucchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antonioli, E., Guglielmelli, P., Pancrazzi, A. et al. Clinical implications of the JAK2 V617F mutation in essential thrombocythemia. Leukemia 19, 1847–1849 (2005). https://doi.org/10.1038/sj.leu.2403902

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403902

This article is cited by

Search

Quick links